Poor survival disease free survival. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Anatomy9

Cell Line, Tumor Lymph Nodes Cells, Cultured Bone Marrow Tumor Cells, Cultured Bile Ducts, Intrahepatic Cell Line Neoplastic Stem Cells Chromosomes, Human, Pair 8

Organisms6

Mice, Inbred C57BL Mice, Nude Mice, Inbred BALB C Mice, Knockout Mice, Transgenic Mice, SCID

Diseases66

Neoplasm Recurrence, Local Breast Neoplasms Lymphatic Metastasis Neoplasm Invasiveness Carcinoma, Squamous Cell Adenocarcinoma Colorectal Neoplasms Liver Neoplasms Carcinoma Recurrence Carcinoma, Ductal, Breast Lung Neoplasms Neoplasm Metastasis Disease Progression Carcinoma, Non-Small-Cell Lung Ovarian Neoplasms Bone Neoplasms Brain Neoplasms Stomach Neoplasms Carcinoma, Hepatocellular Pancreatic Neoplasms Head and Neck Neoplasms Sarcoma Glioblastoma Osteosarcoma Lymphoma, Non-Hodgkin Melanoma Kidney Neoplasms Hodgkin Disease Multiple Myeloma Carcinoma, Renal Cell Neoplasms, Germ Cell and Embryonal Rectal Neoplasms Neoplasm, Residual Prostatic Neoplasms Skin Neoplasms Esophageal Neoplasms Urinary Bladder Neoplasms Adenocarcinoma, Mucinous Colonic Neoplasms Neoplasms Cholangiocarcinoma Mediastinal Neoplasms Carcinoma, Pancreatic Ductal Disease Models, Animal Uterine Cervical Neoplasms Testicular Neoplasms Postoperative Complications Precursor Cell Lymphoblastic Leukemia-Lymphoma Nasopharyngeal Neoplasms Soft Tissue Neoplasms Gastrointestinal Neoplasms Glioma Bile Duct Neoplasms Endometrial Neoplasms Mesothelioma Neuroblastoma Mouth Neoplasms Leukemia, Myeloid, Acute Lymphoma, Large B-Cell, Diffuse Neoplasms, Glandular and Epithelial Gallbladder Neoplasms Astrocytoma Chromosome Aberrations Neovascularization, Pathologic Cell Transformation, Neoplastic

Chemicals and Drugs56

Tumor Markers, Biological Fluorouracil Cyclophosphamide Receptor, erbB-2 Receptors, Estrogen Antineoplastic Agents Cisplatin Vincristine Doxorubicin Neoplasm Proteins Receptors, Progesterone Etoposide Methotrexate Prednisone Carboplatin RNA, Messenger Antibodies, Monoclonal Free Radicals Ki-67 Antigen Tumor Suppressor Protein p53 Paclitaxel Antineoplastic Agents, Hormonal Tamoxifen Receptor, Epidermal Growth Factor Deoxycytidine Organoplatinum Compounds Antimetabolites, Antineoplastic Antigens, Neoplasm Antineoplastic Agents, Alkylating Antibodies, Monoclonal, Humanized Leucovorin Proto-Oncogene Proteins RNA, Small Interfering Bleomycin Taxoids Cytarabine MicroRNAs Protein Kinase Inhibitors Antineoplastic Agents, Phytogenic Ifosfamide Antibodies, Monoclonal, Murine-Derived Survival of Motor Neuron 1 Protein Vascular Endothelial Growth Factor A Phosphatidylinositol 3-Kinases Transcription Factors DNA-Binding Proteins Membrane Proteins Tumor Suppressor Proteins Nuclear Proteins Angiogenesis Inhibitors DNA, Neoplasm Twist Transcription Factor Biological Markers L-Lactate Dehydrogenase Antigens, CD PTEN Phosphohydrolase

Analytical, Diagnostic and Therapeutic Techniques and Equipment79

Disease-Free Survival Survival Rate Prognosis Survival Analysis Neoplasm Staging Treatment Outcome Retrospective Studies Kaplan-Meier Estimate Combined Modality Therapy Follow-Up Studies Antineoplastic Combined Chemotherapy Protocols Proportional Hazards Models Immunohistochemistry Chemotherapy, Adjuvant Radiotherapy, Adjuvant Multivariate Analysis Radiotherapy Dosage Immunoenzyme Techniques Predictive Value of Tests Prospective Studies Risk Factors Neoplasm Grading Cohort Studies Remission Induction Neoadjuvant Therapy Drug Administration Schedule Reverse Transcriptase Polymerase Chain Reaction Tissue Array Analysis Risk Assessment Chemoradiotherapy Salvage Therapy Actuarial Analysis Radiotherapy Gene Expression Profiling Lymph Node Excision Transplantation, Homologous Brachytherapy Hepatectomy Hematopoietic Stem Cell Transplantation Transplantation, Autologous Registries Tumor Burden Chi-Square Distribution Blotting, Western Dose Fractionation Case-Control Studies Liver Transplantation Oligonucleotide Array Sequence Analysis Disease Models, Animal Clinical Trials as Topic Bone Marrow Transplantation Risk Analysis of Variance Randomized Controlled Trials as Topic Radiotherapy, Intensity-Modulated Probability Mastectomy Gene Knockdown Techniques In Situ Hybridization, Fluorescence Models, Biological Incidence Tomography, X-Ray Computed Xenograft Model Antitumor Assays Radiotherapy, Conformal Real-Time Polymerase Chain Reaction Severity of Illness Index Cause of Death Life Tables Transplantation, Heterologous Regression Analysis Peripheral Blood Stem Cell Transplantation Kidney Transplantation Polymerase Chain Reaction Neoplasm Transplantation SEER Program Statistics, Nonparametric Renal Dialysis Reproducibility of Results Prostatectomy

Phenomena and Processes35

Cell Survival Time Factors Gene Expression Regulation, Neoplastic Graft Survival Cell Proliferation Apoptosis Signal Transduction Mutation Drug Resistance, Neoplasm Chi-Square Distribution Dose-Response Relationship, Drug Up-Regulation Risk Phosphorylation Gene Expression Cell Movement Probability Down-Regulation Gene Amplification Phenotype Cell Differentiation Graft Rejection Genes, p53 DNA Methylation Microbial Viability Cell Death RNA Interference Tissue Survival Chromosome Aberrations Base Sequence Gene Deletion Genotype Chromosomes, Human, Pair 8 Promoter Regions, Genetic Cell Division

Disciplines and Occupations1

Immunohistochemistry

Anthropology, Education, Sociology and Social Phenomena1

Information Science10

Survival Rate Registries Radiotherapy, Intensity-Modulated Incidence Radiotherapy, Conformal Molecular Sequence Data Cause of Death Life Tables Base Sequence SEER Program

Health Care33

Disease-Free Survival Survival Rate Survival Analysis Treatment Outcome Retrospective Studies Kaplan-Meier Estimate Follow-Up Studies Proportional Hazards Models Multivariate Analysis Predictive Value of Tests Prospective Studies Risk Factors Cohort Studies Age Factors Risk Assessment Actuarial Analysis Registries Chi-Square Distribution Case-Control Studies Clinical Trials as Topic Risk Analysis of Variance Randomized Controlled Trials as Topic Probability Incidence Severity of Illness Index Cause of Death Life Tables Regression Analysis Sex Factors SEER Program Statistics, Nonparametric Reproducibility of Results

Geographicals2

Egypt United States

Anatomy Organisms Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Phenomena and Processes Disciplines and Occupations Anthropology, Education, Sociology and Social Phenomena Information Science Health Care

Disease-Free Survival Survival Rate Prognosis Survival Analysis Neoplasm Staging Treatment Outcome Retrospective Studies Kaplan-Meier Estimate Cell Survival Neoplasm Recurrence, Local Breast Neoplasms Combined Modality Therapy Follow-Up Studies Tumor Markers, Biological Antineoplastic Combined Chemotherapy Protocols Lymphatic Metastasis Proportional Hazards Models Immunohistochemistry Chemotherapy, Adjuvant Radiotherapy, Adjuvant Time Factors Survival Neoplasm Invasiveness Multivariate Analysis Carcinoma, Squamous Cell Adenocarcinoma Fluorouracil Colorectal Neoplasms Radiotherapy Dosage Liver Neoplasms Carcinoma Cyclophosphamide Gene Expression Regulation, Neoplastic Recurrence Graft Survival Immunoenzyme Techniques Receptor, erbB-2 Predictive Value of Tests Prospective Studies Receptors, Estrogen Carcinoma, Ductal, Breast Lung Neoplasms Neoplasm Metastasis Risk Factors Antineoplastic Agents Cisplatin Disease Progression Neoplasm Grading Cell Line, Tumor Carcinoma, Non-Small-Cell Lung Ovarian Neoplasms Cohort Studies Vincristine Bone Neoplasms Doxorubicin Brain Neoplasms Stomach Neoplasms Remission Induction Neoadjuvant Therapy Carcinoma, Hepatocellular Pancreatic Neoplasms Age Factors Neoplasm Proteins Head and Neck Neoplasms Sarcoma Cell Proliferation Apoptosis Receptors, Progesterone Drug Administration Schedule Reverse Transcriptase Polymerase Chain Reaction Etoposide Tissue Array Analysis Glioblastoma Osteosarcoma Risk Assessment Chemoradiotherapy Salvage Therapy Lymph Nodes Methotrexate Actuarial Analysis Signal Transduction Prednisone Radiotherapy Gene Expression Profiling Lymphoma, Non-Hodgkin Melanoma Lymph Node Excision Carboplatin Transplantation, Homologous Mutation Kidney Neoplasms Hodgkin Disease RNA, Messenger Brachytherapy Hepatectomy Antibodies, Monoclonal Drug Resistance, Neoplasm Free Radicals Hematopoietic Stem Cell Transplantation Transplantation, Autologous

No FAQ available that match "poor survival disease free survival"